Erratum: Association of Gensini Score with 30-Day Mortality Rates in Acute Coronary Syndrome Patients in China - Report - MDSpire

Erratum: Association of Gensini Score with 30-Day Mortality Rates in Acute Coronary Syndrome Patients in China

  • By

  • Yi Zhang

  • Rong Luo

  • Xiaochen Sun

  • Jiasheng Cai

  • Mohammed Ahmed Al-Kaif

  • Zhonghua Wang

  • Chunlei Li

  • Chuntao Wu

  • Zilong Wang

  • Zhuqin Li

  • Haibo Liu

  • April 15, 2026

  • 0 min

Share

Clinical Report: Erratum: Association of Gensini Score with 30-Day Mortality Rates

Overview

This report addresses the correction of the author's name in the study on the Gensini score's association with 30-day mortality rates in acute coronary syndrome patients in China. The original findings remain unchanged, emphasizing the importance of accurate author attribution in clinical research.

Background

Accurate author identification is crucial in clinical research to maintain the integrity of published findings. The Gensini score is a significant prognostic tool in assessing coronary artery disease severity, which can influence patient management and outcomes in acute coronary syndrome. Understanding the relationship between the Gensini score and mortality rates can guide clinical decision-making.

Data Highlights

No numerical data or trial results were provided in the erratum.

Key Findings

  • The author's name was corrected from Mohammed Ahmed Akkaif to Mohammed Ahmed Al-Kaif.
  • The original study's findings regarding the Gensini score and mortality rates remain valid.
  • Accurate author attribution is essential for the credibility of clinical research.
  • Related studies emphasize the importance of angiographic assessment in risk stratification for acute coronary syndrome.
  • Recent guidelines highlight the role of anatomical scoring systems in complementing clinical risk assessments.

Clinical Implications

Clinicians should ensure they reference the correct authorship in studies to uphold the integrity of the literature. The Gensini score remains a valuable tool in evaluating the prognosis of acute coronary syndrome patients, influencing treatment strategies and patient outcomes.

Conclusion

This erratum serves as a reminder of the importance of accurate authorship in clinical publications. The findings related to the Gensini score's prognostic value continue to be relevant for patient management in acute coronary syndrome.

References

  1. BMC Cardiovascular Disorders, 2025 -- Erratum: Association of Gensini Score with 30-Day Mortality Rates in Acute Coronary Syndrome Patients in China
  2. Clinical Research in Cardiology — Erratum: A 25-Year Follow-Up on Newly Developed Aortic Dilation in the Population
  3. European Journal of Preventive Cardiology — Correction
  4. Clinical Research in Cardiology — Amendment: Associations of Sympathetic Indicators and Heart Rate Cutoffs for Cardiovascular Risk in Chronic Heart Failure
  5. Clinical Research in Cardiology — Early In-Hospital Heart Rate Correlates with Long-Term Survival Outcomes in Acute Ischemic Stroke Patients
  6. ACC, AHA Issue New Acute Coronary Syndromes Guideline - American College of Cardiology
  7. Impact of Coronary Artery Disease Extent on GRACE Risk Score Prognostic Performance After ST‐Segment–Elevation Myocardial Infarction - PMC
  8. The relationship between Gensini score and rates of 30-day mortality in acute coronary syndrome patients in China - PubMed

Original Source(s)

Erratum: Association of Gensini Score with 30-Day Mortality Rates in Acute Coronary Syndrome Patients in China

  • by Yi Zhang, Rong Luo, Xiaochen Sun, Jiasheng Cai, Mohammed Ahmed Al-Kaif, Zhonghua Wang, Chunlei Li, Chuntao Wu, Zilong Wang, Zhuqin Li, Haibo Liu

  • April 15, 2026

Related Content

Pregnancy-Linked SCAD More Severe

Data presented at the American College of Cardiology 75th Annual Scientific Session linked pregnancy-associated SCAD to more severe presentation and higher in-hospital major adverse cardiovascular events.

Utilizing Optical Coherence Tomography Angiography and Optical Coherence Tomography for the Prediction of Polyvascular Disease

AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.